[Alteration of PHA stimulation and of cytochemical behaviour of lymphocytes from patients with Hodgkin's disease and bronchogenic carcinoma induced by 60Co radiotherapy (author's transl)].
D002283:Carcinoma, Bronchogenic / Q000532:radiotherapy*; D003037:Cobalt Radioisotopes / Q000627:therapeutic use*; D004247:DNA / Q000378:metabolism; D005966:Glucuronidase / Q000378:metabolism; D006689:Hodgkin Disease / Q000378:metabolism / Q000532:radiotherapy*; D006801:Humans; D037102:Lectins / Q000494:pharmacology / Q000528:radiation effects*; D007958:Leukocyte Count; D008175:Lung Neoplasms / Q000532:radiotherapy*; D008213:Lymphocyte Activation / Q000187:drug effects / Q000528:radiation effects*; D008214:Lymphocytes / Q000201:enzymology / Q000378:metabolism / Q000528:radiation effects; D011830:Radiation Effects; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D003037:Cobalt Radioisotopes; D037102:Lectins; D014316:Tritium; D004247:DNA; D005966:Glucuronidase; D013936:Thymidine
Uber den Einfluss energiereicher Strahlen (60Co) auf PHA-Stimulierbarkeit und cytochemisches Verhalten von Lymphocyten bei Morbus Hodgkin und Bronchialcarcinom